KLF7-regulated ITGA2 as a therapeutic target for inhibiting oral cancer stem cells
Xin Qi,
No information about this author
Zhou Jiang,
No information about this author
Pan Wang
No information about this author
et al.
Cell Death and Disease,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: May 2, 2025
Language: Английский
Integrated bulk and single-cell RNA sequencing unveils the temporal and spatial dynamics of epidermal cell adhesion
Qingbo Zheng,
No information about this author
Pengjia Bao,
No information about this author
Xiaoyun Wu
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142601 - 142601
Published: March 1, 2025
Language: Английский
KLF7-Regulated ITGA2 as a Therapeutic Target for Inhibiting Oral Cancer Stem Cells
Xin Qi,
No information about this author
Zhou Jiang,
No information about this author
Pan Wang
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 5, 2024
Abstract
Cancer
stem
cells
(CSCs)
play
crucial
roles
in
tumor
metastasis,
therapy
resistance,
and
immune
evasion.
Identifying
understanding
the
factors
that
regulate
stemness
of
presents
promising
opportunities
for
developing
effective
therapeutic
strategies.
In
this
study
on
oral
squamous
cell
carcinoma
(OSCC),
we
confirmed
key
role
KLF7
maintaining
OSCC.
Using
chromatin
immunoprecipitation
sequencing
dual-luciferase
assays,
identified
ITGA2,
a
membrane
receptor,
as
downstream
gene
regulated
by
maintenance
stemness.
Tumor
sphere
formation
flow
cytometry
analyses,
vivo
limiting
dilution
tumorigenicity
evaluations
demonstrated
knocking
down
ITGA2
significantly
impaired
When
bound
to
its
ECM
ligand,
type
I
collagen,
activates
several
stemness-related
pathways,
including
PI3K-AKT,
MAPK,
Hippo.
TC-I
15,
which
inhibits
ITGA2–collagen
interaction,
showed
synergistic
anti-tumor
effect
when
combined
with
cisplatin
both
vitro
xenograft
models.
summary,
reveal
KLF7/ITGA2
axis
is
modulator
Our
findings
suggest
target,
offering
novel
anti-CSC
strategy.
Highlights
1)
molecule
cancer
2)
ITGA2as
3)
interacts
extracellular
matrix
activating
pathways
promoting
YAP1
nuclear
translocation
sustain
OCSCs.
4)
providing
new
strategy
overcome
OSCC
drug
resistance.
Language: Английский
KLF7-Regulated ITGA2 as a Therapeutic Target for Inhibiting Oral Cancer Stem Cells
Jiong Lyu,
No information about this author
Xin Qi,
No information about this author
Haoran Li
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 4, 2024
Abstract
Cancer
stem
cells
(CSCs)
play
crucial
roles
in
tumor
metastasis,
therapy
resistance,
and
immune
evasion.
Identifying
understanding
the
factors
that
regulate
stemness
of
presents
promising
opportunities
for
developing
effective
therapeutic
strategies.
In
this
study
on
oral
squamous
cell
carcinoma
(OSCC),
we
confirmed
key
role
KLF7
maintaining
OSCC.
Using
chromatin
immunoprecipitation
sequencing
dual-luciferase
assays,
identified
ITGA2,
a
membrane
receptor,
as
downstream
gene
regulated
by
maintenance
stemness.
Tumor
sphere
formation
flow
cytometry
analyses,
vivo
limiting
dilution
tumorigenicity
evaluations
demonstrated
knocking
down
ITGA2
significantly
impaired
When
bound
to
its
ECM
ligand,
type
I
collagen,
activates
several
stemness-related
pathways,
including
PI3K-AKT,
MAPK,
Hippo.
TC-I
15,
which
inhibits
ITGA2–collagen
interaction,
showed
synergistic
anti-tumor
effect
when
combined
with
cisplatin
both
in
vitro
xenograft
models.
summary,
reveal
KLF7/ITGA2
axis
is
modulator
Our
findings
suggest
target,
offering
novel
anti-CSC
strategy.
Language: Английский
Modeling metabolic-associated steatohepatitis with human pluripotent stem cell-derived liver organoids
Hepatology Communications,
Journal Year:
2024,
Volume and Issue:
8(12)
Published: Nov. 29, 2024
Background:
Metabolic-associated
steatohepatitis
(MASH)
is
one
of
the
most
prevalent
liver
diseases
worldwide,
with
a
global
prevalence
estimated
between
3%
and
5%,
posing
significant
health
burden.
Human
organoids
(HLOs)
have
previously
been
generated
to
model
steatohepatitis,
offering
potential
cellular
disease
for
studying
MASH.
However,
current
HLO
lacks
detailed
molecular
characterizations
requires
further
improvement.
Methods:
HLOs
derived
from
human
pluripotent
stem
cells
were
treated
oleic
acid
TGFβ
mimic
MASH
progression.
Treated
then
analyzed
using
both
bulk
single-cell
RNA
sequencing.
Functional
characterization
was
performed
through
staining
BODIPY,
TMRM,
CellROX,
Collagen
I,
as
well
terminal
deoxynucleotidyl
transferase
dUTP
nick
end
labeling
ELISA
assays.
In
addition,
test
validate
hepatoprotective
effects
several
herb
extracts
also
conducted.
Results:
Both
RNA-seq
sequencing
demonstrated
close
resemblance
multiple
signatures
key
intercellular
communications
in
hepatocyte-like
stellate-like
model,
compared
Furthermore,
functional
revealed
progressive
features
including
severe
steatosis,
oxidative
stress,
mitochondrial
dysfunction,
inflammation,
fibrosis.
Schisandra
antioxidative,
anti-inflammatory,
antifibrotic
properties
context
Conclusions:
This
study
offers
an
improved
MASH,
which
can
be
potentially
applied
facilitate
understanding
pathogenesis
discovery
effective
treatments.
Language: Английский